CIK: 1787362 - Address: C/o Igm Biosciences, Inc., 325 E. Middlefield Road, Mountain View, CA 94043
27 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

3/15/24 19:49
3/13/24
IGMSIgm Biosciences, Inc.DEHealthDrugPharmaceutical PreparationsKeyt BruceCAOChief ScS.m-4010.010-4-2176D
12/15/23 19:19
12/13/23
IGMSIgm Biosciences, Inc.DEHealthDrugPharmaceutical PreparationsKeyt BruceCAOChief ScS-445.780-8-5131D
11/29/23 20:47
11/27/23
IGMSIgm Biosciences, Inc.DEHealthDrugPharmaceutical PreparationsKeyt BruceCAOChief ScS-55.060-1-1138D
5/25/23 19:21
5/23/23
IGMSIgm Biosciences, Inc.DEHealthDrugPharmaceutical PreparationsKeyt BruceCAOChief ScS-1212.310-1-1139D
3/16/23 18:30
3/14/23
IGMSIgm Biosciences, Inc.DEHealthDrugPharmaceutical PreparationsKeyt BruceCAOChief ScS-2418.730-1-192D
12/20/22 20:07
12/16/22
IGMSIgm Biosciences, Inc.DEHealthDrugPharmaceutical PreparationsKeyt BruceCAOChief ScS-10218.980-5-859D
11/28/22 20:29
11/23/22
IGMSIgm Biosciences, Inc.DEHealthDrugPharmaceutical PreparationsKeyt BruceCAOChief ScS-1921.570-1-240D
10/6/22 19:16
10/4/22
IGMSIgm Biosciences, Inc.DEHealthDrugPharmaceutical PreparationsKeyt BruceCAOChief ScS.d-57122.840-25-3841D
9/8/22 17:34
9/6/22
IGMSIgm Biosciences, Inc.DEHealthDrugPharmaceutical PreparationsKeyt BruceCAOChief ScS.dm-48419.340-25-3841D
8/22/22 19:21
8/18/22
IGMSIgm Biosciences, Inc.DEHealthDrugPharmaceutical PreparationsKeyt BruceCAOChief ScS.dm-55422.170-25-3841D
5/26/22 16:46
5/24/22
IGMSIgm Biosciences, Inc.DEHealthDrugPharmaceutical PreparationsKeyt BruceCAOChief ScS-1617.100-1-241D
4/8/22 19:24
4/6/22
IGMSIgm Biosciences, Inc.DEHealthDrugPharmaceutical PreparationsKeyt BruceCAOChief ScS.d-6325.000-3-641D
4/1/22 20:16
3/30/22
IGMSIgm Biosciences, Inc.DEHealthDrugPharmaceutical PreparationsKeyt BruceCAOChief ScS.d-21428.500-8-1541D
11/3/21 19:55
11/2/21
IGMSIgm Biosciences, Inc.DEHealthDrugPharmaceutical PreparationsKeyt BruceCAOChief ScS.d-6851.370-1-254D
10/5/21 21:28
10/5/21
IGMSIgm Biosciences, Inc.DEHealthDrugPharmaceutical PreparationsKeyt BruceCAOChief ScS.d-8064.100-1-234D
9/3/21 20:23
9/3/21
IGMSIgm Biosciences, Inc.DEHealthDrugPharmaceutical PreparationsKeyt BruceCAOChief ScS.d-8870.690-1-234D
8/4/21 20:42
8/4/21
IGMSIgm Biosciences, Inc.DEHealthDrugPharmaceutical PreparationsKeyt BruceCAOChief ScS.d-8367.000-1-234D
7/6/21 19:46
7/6/21
IGMSIgm Biosciences, Inc.DEHealthDrugPharmaceutical PreparationsKeyt BruceCAOChief ScS.d-10382.500-1-234D
6/3/21 20:30
6/2/21
IGMSIgm Biosciences, Inc.DEHealthDrugPharmaceutical PreparationsKeyt BruceCAOChief ScS.d-9979.150-1-234D
5/5/21 21:31
5/5/21
IGMSIgm Biosciences, Inc.DEHealthDrugPharmaceutical PreparationsKeyt BruceCAOChief ScS.d-7862.500-1-254D
4/7/21 21:24
4/6/21
IGMSIgm Biosciences, Inc.DEHealthDrugPharmaceutical PreparationsKeyt BruceCAOChief ScS.d-10382.000-1-254D
3/3/21 21:43
3/2/21
IGMSIgm Biosciences, Inc.DEHealthDrugPharmaceutical PreparationsKeyt BruceCAOChief ScS.d-14690.250-2-304D
2/4/21 20:12
2/3/21
IGMSIgm Biosciences, Inc.DEHealthDrugPharmaceutical PreparationsKeyt BruceCAOChief ScS.d-15596.000-2-304D
1/6/21 20:39
1/4/21
IGMSIgm Biosciences, Inc.DEHealthDrugPharmaceutical PreparationsKeyt BruceCAOChief ScS.dm-19782.560-2-394M
12/18/20 19:47
12/17/20
IGMSIgm Biosciences, Inc.DEHealthDrugPharmaceutical PreparationsKeyt BruceCAOChief ScS.d-13986.100-2-265D
10/5/20 17:50
10/1/20
IGMSIgm Biosciences, Inc.DEHealthDrugPharmaceutical PreparationsKeyt BruceCAOChief ScS-7473.590-1-185I
9/14/20 20:43
9/10/20
IGMSIgm Biosciences, Inc.DEHealthDrugPharmaceutical PreparationsKeyt BruceCAOChief ScS-6060.000-1-156I

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact